Back to Search
MICHELLE MAYES, PHARMD
PHARMD
Pharmacist
NPI: 1649800749Individual
Specialties, Licenses & Credentials
PharmacistPrimary
Pharmacist
Code: 183500000X
066450(NY)
Research & Publications (20)
Major histocompatibility complex (MHC) class II alleles, haplotypes and epitopes which confer susceptibility or protection in systemic sclerosis: analyses in 1300 Caucasian, African-American and Hispanic cases and 1000 controls.
PMID 19596691·Ann Rheum Dis·2010
4-observational
Gastric slow waves, gastrointestinal symptoms and peptides in systemic sclerosis patients.
PMID 19566588·Neurogastroenterol Motil·2009
8-other
Lack of evidence for bacterial infections in skin in patients with systemic sclerosis.
PMID 19402205·Am J Med Sci·2009
8-other
Recombinant human relaxin in the treatment of systemic sclerosis with diffuse cutaneous involvement: a randomized, double-blind, placebo-controlled trial.
PMID 19333948·Arthritis Rheum·2009
3-trial
MQX-503, a novel formulation of nitroglycerin, improves the severity of Raynaud's phenomenon: a randomized, controlled trial.
PMID 19248104·Arthritis Rheum·2009
4-observational
A multicenter, randomized, double-blind, placebo-controlled trial of oral type I collagen treatment in patients with diffuse cutaneous systemic sclerosis: I. oral type I collagen does not improve skin in all patients, but may improve skin in late-phase disease.
PMID 18512816·Arthritis Rheum·2008
4-observational
Development of a provisional core set of response measures for clinical trials of systemic sclerosis.
PMID 17893248·Ann Rheum Dis·2008
8-other
Validity, reliability, and feasibility of durometer measurements of scleroderma skin disease in a multicenter treatment trial.
PMID 18438905·Arthritis Rheum·2008
4-observational
Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part I.
PMID 18163481·Arthritis Rheum·2008
8-other
Effect of increased pigmentation on the antifibrotic response of human skin to UV-A1 phototherapy.
PMID 18645136·Arch Dermatol·2008
2-rct
Effects of 1-year treatment with cyclophosphamide on outcomes at 2 years in scleroderma lung disease.
PMID 17717203·Am J Respir Crit Care Med·2007
4-observational
Disease and symptom burden in systemic sclerosis: a patient perspective.
PMID 17611983·J Rheumatol·2007
8-other
High-dose immunosuppressive therapy and autologous hematopoietic cell transplantation for severe systemic sclerosis: long-term follow-up of the US multicenter pilot study.
PMID 17452515·Blood·2007
4-observational
Impact of oral cyclophosphamide on health-related quality of life in patients with active scleroderma lung disease: results from the scleroderma lung study.
PMID 17469162·Arthritis Rheum·2007
2-rct
Scleroderma lung study (SLS): differences in the presentation and course of patients with limited versus diffuse systemic sclerosis.
PMID 17485423·Ann Rheum Dis·2007
4-observational
An allograft inflammatory factor 1 (AIF1) single nucleotide polymorphism (SNP) is associated with anticentromere antibody positive systemic sclerosis.
PMID 17522098·Rheumatology (Oxford)·2007
4-observational
Clinical, immunologic, and genetic features of familial systemic sclerosis.
PMID 17530643·Arthritis Rheum·2007
8-other
Development of a preliminary scleroderma gastrointestinal tract 1.0 quality of life instrument.
PMID 17907224·Arthritis Rheum·2007
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 432 PORTER AVE
BUFFALO, NY 14201 - Phone
- (970) 980-9639
Quick Facts
- NPI
- 1649800749
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile